Scholar Rock (SRRK)
(Delayed Data from NSDQ)
$9.43 USD
+0.04 (0.43%)
Updated Jun 13, 2024 04:00 PM ET
Pre-Market: $9.40 -0.03 (-0.32%) 8:44 AM ET
4-Sell of 5 4
F Value F Growth D Momentum F VGM
Brokerage Reports
Scholar Rock Holding Corporation [SRRK]
Reports for Purchase
Showing records 61 - 80 ( 122 total )
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Scholar Rock is Decoding TGF-a Signaling to Unlock its Untapped Therapeutic Power; Initiate at Buy and $24 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: KING M
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Apitegromab Leaves No Stone Unturned at MDA 2022
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
KOL is Buzzing for Apitegromab?s Potential in SMA
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Company: Scholar Rock Holding Corporation
Industry: Medical - Biomedical and Genetics
Twelve-Month Data Around the Corner, Will It Rock?
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D